Literature DB >> 11170644

Coumarin and chromen-4-one analogues as tautomerase inhibitors of macrophage migration inhibitory factor: discovery and X-ray crystallography.

M Orita1, S Yamamoto, N Katayama, M Aoki, K Takayama, Y Yamagiwa, N Seki, H Suzuki, H Kurihara, H Sakashita, M Takeuchi, S Fujita, T Yamada, A Tanaka.   

Abstract

Macrophage migration inhibitory factor (MIF) is a proinflammatory cytokine released from T-cells and macrophages. Although a detailed understanding of the biological functions of MIF has not yet been clarified, it is known that MIF catalyzes the tautomerization of a nonphysiological molecule, D-dopachrome. Using a structure-based computer-assisted search of two databases of commercially available compounds, we have found 14 novel tautomerase inhibitors of MIF whose K(i) values are in the range of 0.038-7.4 microM. We also have determined the crystal structure of MIF complexed with the hit compound 1. It showed that the hit compound is located in the active site of MIF containing the N-terminal proline which plays an important role in the tautomerase reaction and forms several hydrogen bonds and undergoes hydrophobic interactions. A crystallographic study also revealed that there is a hydrophobic surface which consists of Pro-33, Tyr-36, Trp-108, and Phe-113 at the rim of the active site of MIF, and molecular modeling studies indicated that several more potent hit compounds have the aromatic rings which can interact with this hydrophobic surface. To our knowledge, our compounds are the most potent tautomerase inhibitors of MIF. One of these small, drug-like molecules has been cocrystallized with MIF and binds to the active site for tautomerase activity. Molecular modeling also suggests that the other hit compounds can bind in a similar fashion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11170644     DOI: 10.1021/jm000386o

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  24 in total

1.  A virtual active compound produced from the negative image of a ligand-binding pocket, and its application to in-silico drug screening.

Authors:  Yoshifumi Fukunishi; Satoru Kubota; Chisato Kanai; Haruki Nakamura
Journal:  J Comput Aided Mol Des       Date:  2006-06-21       Impact factor: 3.686

2.  Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential.

Authors:  Joshua Bloom; Christine Metz; Saisha Nalawade; Julian Casabar; Kai Fan Cheng; Mingzhu He; Barbara Sherry; Thomas Coleman; Thomas Forsthuber; Yousef Al-Abed
Journal:  J Biol Chem       Date:  2016-10-28       Impact factor: 5.157

3.  Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor.

Authors:  Vinay Trivedi-Parmar; William L Jorgensen
Journal:  J Med Chem       Date:  2018-06-04       Impact factor: 7.446

4.  Aza-derivatives of resveratrol are potent macrophage migration inhibitory factor inhibitors.

Authors:  Yoshihiko Fujita; Rafiqul Islam; Kazuko Sakai; Hiroyasu Kaneda; Kanae Kudo; Daisuke Tamura; Keiichi Aomatsu; Tomoyuki Nagai; Hidekazu Kimura; Kazuko Matsumoto; Marco A de Velasco; Tokuzo Arao; Tadashi Okawara; Kazuto Nishio
Journal:  Invest New Drugs       Date:  2011-09-13       Impact factor: 3.850

Review 5.  MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.

Authors:  Pathricia V Tilstam; Dake Qi; Lin Leng; Lawrence Young; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2017-07       Impact factor: 6.902

Review 6.  Mechanisms of macrophage migration inhibitory factor (MIF)-dependent tumor microenvironmental adaptation.

Authors:  Beatriz E Rendon; Sharon S Willer; Wayne Zundel; Robert A Mitchell
Journal:  Exp Mol Pathol       Date:  2009-01-07       Impact factor: 3.362

7.  Structural and kinetic analyses of macrophage migration inhibitory factor active site interactions.

Authors:  Gregg V Crichlow; Jodi B Lubetsky; Lin Leng; Richard Bucala; Elias J Lolis
Journal:  Biochemistry       Date:  2009-01-13       Impact factor: 3.162

8.  Discovery of human macrophage migration inhibitory factor (MIF)-CD74 antagonists via virtual screening.

Authors:  Zoe Cournia; Lin Leng; Sunilkumar Gandavadi; Xin Du; Richard Bucala; William L Jorgensen
Journal:  J Med Chem       Date:  2009-01-22       Impact factor: 7.446

9.  The conformational flexibility of the carboxy terminal residues 105-114 is a key modulator of the catalytic activity and stability of macrophage migration inhibitory factor.

Authors:  Farah El-Turk; Michele Cascella; Hajer Ouertatani-Sakouhi; Raghavendran Lakshmi Narayanan; Lin Leng; Richard Bucala; Markus Zweckstetter; Ursula Rothlisberger; Hilal A Lashuel
Journal:  Biochemistry       Date:  2008-09-17       Impact factor: 3.162

10.  The crystal structures of macrophage migration inhibitory factor from Plasmodium falciparum and Plasmodium berghei.

Authors:  Sarah E Dobson; Kevin D Augustijn; James A Brannigan; Claudia Schnick; Chris J Janse; Eleanor J Dodson; Andrew P Waters; Anthony J Wilkinson
Journal:  Protein Sci       Date:  2009-12       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.